Phlogistix

Phlogistix LLC, established in 2011, focuses on the development, marketing, and licensing of neurodiagnostic and therapeutic technologies specifically targeting neuroinflammation and related disorders. The company is at the forefront of research in areas such as traumatic brain injury, sports-related concussions, and mitochondrial releasates therapeutics.

With a commitment to innovation, Phlogistix serves as a nexus for coagulation and inflammation diagnostics, striving to enhance companion diagnostics and theranostic drugs. As it continues its active discovery phase, the organization plays a vital role in advancing understanding and treatment options for conditions like PTSD, CTE, and mTBI.

Generated from the website